We are excited to announce that the 16th Annual CHI Immunogenicity & Bioassay Summit will take place this fall in Washington, DC! This year, we are proud to welcome back Chairs from the HESI Immuno-Safety Technical Committee’s Immunogenicity Pilot Study Project returning to share fresh insights from their ongoing research with our community.
Dr. Laurent Malherbe (Eli Lilly) will present "HESI/AAPS: Towards Harmonization of in vitro T Cell Assays to Predict Immunogenicity of Biologics" at 5:00 PM on Thursday, October 17th. This work is collaborative HESI/AAPS effort to develop a monoclonal antibody reference panel for preclinical immunogenicity risk assessment. Don't miss this opportunity to stay informed and connect with leading experts in the field.
We look forward to seeing you there!
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-8403
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.